SCHEMBL14103783

SCHEMBL14103783

Oc1nc(-c2ccc(F)c(Cl)c2)nc2ccsc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CSNK2A1 P68400 2/20 0.40
▸ TSPO P30536 1/20 0.39
▸ ABL1 P00519 1/20 0.38
▸ PIK3CA P42336 4/20 0.37
▸ MTOR P42345 3/20 0.37
▸ HSD17B14 Q9BPX1 1/20 0.37
▸ PIK3C2B O00750 1/20 0.37
▸ CCNE2 O96020 1/20 0.37
▸ PRKACA P17612 1/20 0.37
▸ PRKACG P22612 1/20 0.37
▸ PRKACB P22694 1/20 0.37
▸ CCNE1 P24864 1/20 0.37
▸ CDK2 P24941 1/20 0.37
▸ KDR P35968 1/20 0.37
▸ PIK3CB P42338 1/20 0.37
▸ PIK3CG P48736 1/20 0.37
▸ NPC1 O15118 2/20 0.36
▸ RAB9A P51151 2/20 0.36
▸ CASP1 P29466 1/20 0.36
▸ KMO O15229 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14104151 0.87 PIK3CA (0.39) CSNK2A1PIK3CAMTORPIK3C2BCCNE2
SCHEMBL14104413 0.87 CSNK2A1 (0.42) CSNK2A1TSPOABL1NPC1RAB9A
SCHEMBL14103742 0.83 RAB9A (0.43) PIK3CAMTORPIK3C2BCCNE2PRKACA
SCHEMBL14103741 0.80 MAPT (0.49) PIK3CAMTORPIK3C2BCCNE2PRKACA
SCHEMBL14104415 0.78 PIK3CA (0.46) CSNK2A1PIK3CAMTORPIK3C2BCCNE2
SCHEMBL14104146 0.77 AXL (0.40) CSNK2A1PIK3CAMTORPIK3C2BCCNE2
SCHEMBL14104075 0.77 CYP1A2 (0.40) CSNK2A1TSPOKDRABCG2MAPT
SCHEMBL14095203 0.77 PRKCI (0.39) PIK3CAMTORPIK3C2BCCNE2PRKACA
SCHEMBL13789439 0.76 AXL (0.39) CSNK2A1ABL1PIK3CAMTORPIK3C2B
SCHEMBL14095156 0.75 CASP3 (0.45) PIK3CAMTORPIK3C2BCCNE2PRKACA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008092861-A1 BICYCLIC DERIVATIVES AS EP4 AGONISTS JANSSEN PHARMACEUTICA N.V. (BE) 2008-08-07 — — WO disclosed
Send feedback